Cinacalcet lowers serum alkaline phosphatase in maintenance hemodialysis patients (Q37123151)

18 August 2017

Cinacalcet lowers serum alkaline phosphatase in maintenance hemodialysis patients (English)

1 reference

18 August 2017

1 reference

Kamyar Kalantar-Zadeh

4

object named as

Kamyar Kalantar-Zadeh

0 references

author name string

Vasily Belozeroff

1

1 reference

PMCID

2653659

18 August 2017

William G Goodman

2

1 reference

PMCID

2653659

18 August 2017

Lulu Ren

3

1 reference

18 August 2017

4 March 2009

1 reference

Clinical Journal of the American Society of Nephrology

18 August 2017

1 reference

18 August 2017

4

1 reference

18 August 2017

3

1 reference

18 August 2017

673-679

1 reference

Serum alkaline phosphatase predicts mortality among maintenance hemodialysis patients

18 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2653659

Upregulation of alkaline phosphatase and pyrophosphate hydrolysis: potential mechanism for uremic vascular calcification

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2653659

Renal osteodystrophy, phosphate homeostasis, and vascular calcification

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2653659

Development and progression of secondary hyperparathyroidism in chronic kidney disease: lessons from molecular genetics

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2653659

Definition, evaluation, and classification of renal osteodystrophy: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO)

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2653659

Cardiovascular calcification in end stage renal disease

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2653659

Physiological changes in extracellular calcium concentration directly control osteoblast function in the absence of calciotropic hormones

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2653659

Pharmacodynamics of the Type II Calcimimetic Compound Cinacalcet HCl

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2653659

Pathophysiology and recent advances in the management of renal osteodystrophy

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2653659

Management of disturbances of calcium and phosphate metabolism in chronic renal insufficiency, with emphasis on the control of hyperphosphataemia.

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2653659

What's the relative risk? A method of correcting the odds ratio in cohort studies of common outcomes

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2653659

Parathyroid hormone exerts disparate effects on osteoblast differentiation depending on exposure time in rat osteoblastic cells

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2653659

Expression and signal transduction of calcium-sensing receptors in cartilage and bone

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2653659

Progressive vascular calcification over 2 years is associated with arterial stiffening and increased mortality in patients with stages 4 and 5 chronic kidney disease

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2653659

Elevated relative mortality risk with mild-to-moderate chronic kidney disease decreases with age.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2653659

Survival predictability of time-varying indicators of bone disease in maintenance hemodialysis patients

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2653659

PTH and the risks for hip, vertebral, and pelvic fractures among patients on dialysis.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2653659

Effects of the calcimimetic cinacalcet HCl on cardiovascular disease, fracture, and health-related quality of life in secondary hyperparathyroidism

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2653659

Activated injectable vitamin D and hemodialysis survival: a historical cohort study

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2653659

Cinacalcet HCl, an oral calcimimetic agent for the treatment of secondary hyperparathyroidism in hemodialysis and peritoneal dialysis: a randomized, double-blind, multicenter study

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2653659

Mineral metabolism, mortality, and morbidity in maintenance hemodialysis.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2653659

Phosphate-induced vascular calcification: role of pyrophosphate and osteopontin

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2653659

Cinacalcet for secondary hyperparathyroidism in patients receiving hemodialysis

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2653659

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2653659

Arterial calcifications, arterial stiffness, and cardiovascular risk in end-stage renal disease

4 December 2018

1 reference

12 December 2020

Arterial media calcification in end-stage renal disease: impact on all-cause and cardiovascular mortality.

1 reference

12 December 2020

Plasma total versus bone alkaline phosphatase as markers of bone turnover in hemodialysis patients

1 reference

12 December 2020

Risk factors for reduced bone density in haemodialysis patients

1 reference

12 December 2020

Predictors and consequences of altered mineral metabolism: the Dialysis Outcomes and Practice Patterns Study

1 reference

12 December 2020

Low turnover osteodystrophy and vascular calcification are amenable to skeletal anabolism in an animal model of chronic kidney disease and the metabolic syndrome

1 reference

12 December 2020

Cinacalcet HCI (Sensipar/Mimpara) is an effective chronic therapy for hemodialysis patients with secondary hyperparathyroidism

1 reference

12 December 2020

12 months cinacalcet therapy in hemodialysis patients with secondary hyperparathyroidism: effect on bone markers

1 reference

12 December 2020

High alkaline phosphatase levels in hemodialysis patients are associated with higher risk of hospitalization and death

1 reference

12 December 2020

Identifiers

DOI

10.2215/CJN.03790808

1 reference

18 August 2017

1 reference

18 August 2017

1 reference

PMCID

2653659